The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Adjuvants-Global Market Insights and Sales Trends 2024

Adjuvants-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1864059

No of Pages : 97

Synopsis
An adjuvant is a pharmacological or immunological agent that modifies the effect of other agents.
The global Adjuvants market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Adjuvants in various end use industries. The expanding demands from the Farming, Veterinary Medicine, Medicine and Vaccin, are propelling Adjuvants market. Adjuvant Emulsions, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pathogen Components segment is estimated at % CAGR for the next seven-year period.
Europe and North America are the dominant markets for adjuvants because of the high prevalence of cancer in the two continents.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Adjuvants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Adjuvants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Adjuvants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Adjuvants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Adjuvants covered in this report include BASF, Syngenta, Bayer CropScience, Novozymes, Koppert Biological Systems, Monsanto, Biobest, Certis USA and Andermatt Biocontrol, etc.
The global Adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BASF
Syngenta
Bayer CropScience
Novozymes
Koppert Biological Systems
Monsanto
Biobest
Certis USA
Andermatt Biocontrol
Global Adjuvants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Adjuvants market, Segment by Type:
Adjuvant Emulsions
Pathogen Components
Particulate Adjuvants
Combination Adjuvants
Global Adjuvants market, by Application
Farming
Veterinary Medicine
Medicine
Vaccin
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Adjuvants Market Overview
1.1 Adjuvants Product Overview
1.2 Adjuvants Market Segment by Type
1.2.1 Adjuvant Emulsions
1.2.2 Pathogen Components
1.2.3 Particulate Adjuvants
1.2.4 Combination Adjuvants
1.3 Global Adjuvants Market Size by Type
1.3.1 Global Adjuvants Market Size Overview by Type (2018-2029)
1.3.2 Global Adjuvants Historic Market Size Review by Type (2018-2023)
1.3.3 Global Adjuvants Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Adjuvants Sales Breakdown by Type (2018-2023)
1.4.2 Europe Adjuvants Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Adjuvants Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Adjuvants Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Adjuvants Sales Breakdown by Type (2018-2023)
2 Global Adjuvants Market Competition by Company
2.1 Global Top Players by Adjuvants Sales (2018-2023)
2.2 Global Top Players by Adjuvants Revenue (2018-2023)
2.3 Global Top Players by Adjuvants Price (2018-2023)
2.4 Global Top Manufacturers Adjuvants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Adjuvants Market Competitive Situation and Trends
2.5.1 Adjuvants Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Adjuvants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adjuvants as of 2022)
2.7 Date of Key Manufacturers Enter into Adjuvants Market
2.8 Key Manufacturers Adjuvants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Adjuvants Status and Outlook by Region
3.1 Global Adjuvants Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Adjuvants Historic Market Size by Region
3.2.1 Global Adjuvants Sales in Volume by Region (2018-2023)
3.2.2 Global Adjuvants Sales in Value by Region (2018-2023)
3.2.3 Global Adjuvants Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Adjuvants Forecasted Market Size by Region
3.3.1 Global Adjuvants Sales in Volume by Region (2024-2029)
3.3.2 Global Adjuvants Sales in Value by Region (2024-2029)
3.3.3 Global Adjuvants Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Adjuvants by Application
4.1 Adjuvants Market Segment by Application
4.1.1 Farming
4.1.2 Veterinary Medicine
4.1.3 Medicine
4.1.4 Vaccin
4.1.5 Others
4.2 Global Adjuvants Market Size by Application
4.2.1 Global Adjuvants Market Size Overview by Application (2018-2029)
4.2.2 Global Adjuvants Historic Market Size Review by Application (2018-2023)
4.2.3 Global Adjuvants Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Adjuvants Sales Breakdown by Application (2018-2023)
4.3.2 Europe Adjuvants Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Adjuvants Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Adjuvants Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Adjuvants Sales Breakdown by Application (2018-2023)
5 North America Adjuvants by Country
5.1 North America Adjuvants Historic Market Size by Country
5.1.1 North America Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Adjuvants Sales in Volume by Country (2018-2023)
5.1.3 North America Adjuvants Sales in Value by Country (2018-2023)
5.2 North America Adjuvants Forecasted Market Size by Country
5.2.1 North America Adjuvants Sales in Volume by Country (2024-2029)
5.2.2 North America Adjuvants Sales in Value by Country (2024-2029)
6 Europe Adjuvants by Country
6.1 Europe Adjuvants Historic Market Size by Country
6.1.1 Europe Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Adjuvants Sales in Volume by Country (2018-2023)
6.1.3 Europe Adjuvants Sales in Value by Country (2018-2023)
6.2 Europe Adjuvants Forecasted Market Size by Country
6.2.1 Europe Adjuvants Sales in Volume by Country (2024-2029)
6.2.2 Europe Adjuvants Sales in Value by Country (2024-2029)
7 Asia-Pacific Adjuvants by Region
7.1 Asia-Pacific Adjuvants Historic Market Size by Region
7.1.1 Asia-Pacific Adjuvants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Adjuvants Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Adjuvants Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Adjuvants Forecasted Market Size by Region
7.2.1 Asia-Pacific Adjuvants Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Adjuvants Sales in Value by Region (2024-2029)
8 Latin America Adjuvants by Country
8.1 Latin America Adjuvants Historic Market Size by Country
8.1.1 Latin America Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Adjuvants Sales in Volume by Country (2018-2023)
8.1.3 Latin America Adjuvants Sales in Value by Country (2018-2023)
8.2 Latin America Adjuvants Forecasted Market Size by Country
8.2.1 Latin America Adjuvants Sales in Volume by Country (2024-2029)
8.2.2 Latin America Adjuvants Sales in Value by Country (2024-2029)
9 Middle East and Africa Adjuvants by Country
9.1 Middle East and Africa Adjuvants Historic Market Size by Country
9.1.1 Middle East and Africa Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Adjuvants Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Adjuvants Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Adjuvants Forecasted Market Size by Country
9.2.1 Middle East and Africa Adjuvants Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Adjuvants Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BASF
10.1.1 BASF Company Information
10.1.2 BASF Introduction and Business Overview
10.1.3 BASF Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BASF Adjuvants Products Offered
10.1.5 BASF Recent Development
10.2 Syngenta
10.2.1 Syngenta Company Information
10.2.2 Syngenta Introduction and Business Overview
10.2.3 Syngenta Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Syngenta Adjuvants Products Offered
10.2.5 Syngenta Recent Development
10.3 Bayer CropScience
10.3.1 Bayer CropScience Company Information
10.3.2 Bayer CropScience Introduction and Business Overview
10.3.3 Bayer CropScience Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bayer CropScience Adjuvants Products Offered
10.3.5 Bayer CropScience Recent Development
10.4 Novozymes
10.4.1 Novozymes Company Information
10.4.2 Novozymes Introduction and Business Overview
10.4.3 Novozymes Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novozymes Adjuvants Products Offered
10.4.5 Novozymes Recent Development
10.5 Koppert Biological Systems
10.5.1 Koppert Biological Systems Company Information
10.5.2 Koppert Biological Systems Introduction and Business Overview
10.5.3 Koppert Biological Systems Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Koppert Biological Systems Adjuvants Products Offered
10.5.5 Koppert Biological Systems Recent Development
10.6 Monsanto
10.6.1 Monsanto Company Information
10.6.2 Monsanto Introduction and Business Overview
10.6.3 Monsanto Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Monsanto Adjuvants Products Offered
10.6.5 Monsanto Recent Development
10.7 Biobest
10.7.1 Biobest Company Information
10.7.2 Biobest Introduction and Business Overview
10.7.3 Biobest Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biobest Adjuvants Products Offered
10.7.5 Biobest Recent Development
10.8 Certis USA
10.8.1 Certis USA Company Information
10.8.2 Certis USA Introduction and Business Overview
10.8.3 Certis USA Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Certis USA Adjuvants Products Offered
10.8.5 Certis USA Recent Development
10.9 Andermatt Biocontrol
10.9.1 Andermatt Biocontrol Company Information
10.9.2 Andermatt Biocontrol Introduction and Business Overview
10.9.3 Andermatt Biocontrol Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Andermatt Biocontrol Adjuvants Products Offered
10.9.5 Andermatt Biocontrol Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Adjuvants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Adjuvants Industrial Chain Analysis
11.4 Adjuvants Market Dynamics
11.4.1 Adjuvants Industry Trends
11.4.2 Adjuvants Market Drivers
11.4.3 Adjuvants Market Challenges
11.4.4 Adjuvants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Adjuvants Distributors
12.3 Adjuvants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’